Zenas BioPharma, Inc. (ZBIO) earnings
ZBIO earnings moved a median of -0.54% by the close. Quarterly and annual ZBIO reports and results, each read against the price at its own news timestamp. Back to the ZBIO overview →
14 measured ZBIO earnings events.
Where these ZBIO earnings landedvs 12 measured ZBIO earnings reactions
| Middle 50% of ZBIO earnings reactions | -1.86% to +2.92% |
|---|---|
| Median reaction (to close) | -0.54% |
| Measured reactions | 12 |
Point-in-time · zero look-ahead
Half of the 12 ZBIO earnings events with a measured close landed between -1.86% and +2.92%; 42% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 10-Q Zenas BioPharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | -2.76% | -3.92% | |
| Zenas BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update | Press release | -2.76% | -3.92% | |
| Form 10-Q Zenas BioPharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.66% | +1.68% | |
| Zenas BioPharma Reports First Quarter 2026 Financial Results and Provides Corporate Update | Press release | -0.66% | +1.68% | |
| Form 10-K Zenas BioPharma, Inc. For: Dec 31 | SEC filing · Form 10-K | -0.21% | -0.51% | |
| Form 10-Q Zenas BioPharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | -1.28% | -0.56% | |
| Zenas BioPharma Reports Third Quarter 2025 Financial Results and Provides Corporate Update | Press release | -1.28% | -0.56% | |
| Form 10-Q Zenas BioPharma, Inc. For: Jun 30 | SEC filing · Form 10-Q | — | — | |
| Zenas BioPharma Reports Second Quarter 2025 Financial Results and Provides Corporate Updates | Press release | — | — | |
| Form 10-Q Zenas BioPharma, Inc. For: Mar 31 | SEC filing · Form 10-Q | -0.11% | +6.80% | |
| Zenas BioPharma Reports First Quarter 2025 Financial Results and Provides Corporate Updates | Press release | -0.11% | +6.80% | |
| Form 10-K Zenas BioPharma, Inc. For: Dec 31 | SEC filing · Form 10-K | +0.61% | +6.62% | |
| Form 10-Q Zenas BioPharma, Inc. For: Sep 30 | SEC filing · Form 10-Q | — | -1.73% | |
| Zenas BioPharma Reports Third Quarter 2024 Financial Results and Provides Corporate Updates | Press release | -0.28% | -2.23% |
Keep exploring
More ZBIO: analyst actions → · SEC filings → · ZBIO overview →